🇺🇸 FDA
Company

IO

IO Biotech

IOBTQ biotech USA

Quick answer

IO is a biotech company (IOBTQ) headquartered in COPENHAGEN, G7, USA with 13 tracked pipeline programs.

Pipeline (13)

project

IO102-IO103

Metastatic Melanoma

Phase 3 · small_molecule · active

1 trials project

IO102

NSCLC

Phase 2 · mab · completed

1 trials project

IO102-IO103 in combination with pembrolizumab

Lung Cancer Non Small Cell

Phase 2 · small_molecule · completed

1 trials project

IO102/IO103

Melanoma

Phase 2 · small_molecule · active

2 trials project

IRX4204

Psoriasis

Phase 2 · small_molecule · on_hold

1 trials project

NRX 194204

Castration Resistant Prostate Cancer

Phase 2 · small_molecule · completed

1 trials project

PD-L1 peptide

Smoldering Multiple Myeloma

Phase 2 · mab · terminated

1 trials project

PD-L1, PD-L2 peptides with Montanide ISA51

Chronic Lymphocytic Leukemia

Phase 2 · other · completed

1 trials project

Pembrolizumab

Head and Neck Squamous Cell Carcinoma

Phase 2 · small_molecule · active

1 trials project

IRX4204

Parkinson's Disease

Phase 1 · small_molecule · completed

1 trials project

IRX4204

Lung Cancer, Nonsmall Cell

Phase 1 · small_molecule · terminated

1 trials project

IRX5183

Acute Myeloid Leukemia (AML)

Phase 1 · small_molecule · terminated

1 trials project

PD-L1/IDO Peptide Vaccine

High Risk Non-Muscle Invasive Bladder Urothelial Carcinoma

Phase 1 · mab · active

1 trials

Patents (8)

patent

US 12234288

Immunogenic arginase 2 polypeptides

Expires Mon Feb 20 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12233103

Indoleamine 2,3-dioxygenase based immunotherapy

Expires Mon Feb 20 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12215135

PDL2 compounds

Expires Mon Jan 30 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12194081

ARGINASE1 polypeptides

Expires Mon Jan 09 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12187782

PDL1 peptides for use in cancer vaccines

Expires Mon Jan 02 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12077785

Chimeric antigen receptor polypeptides in combination with trans metabolism mole

Expires Mon Aug 29 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 11981944

Immunogenic arginase peptides

Expires Mon May 09 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 11878053

Vaccine compositions comprising tryptophan 2,3-dioxygenase or fragments thereof

Expires Mon Jan 18 2044 00:00:00 GMT+0000 (Coordinated Universal Time)